関連する実験動画
Updated: Sep 9, 2025

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
5.4K
ウビキチンリガゼHUWE1による薬剤のような小分子の選択的ユビキチン化
Barbara Orth1, Pavel Pohl1, Florian Aust1
1Max Planck Institute for Multidisciplinary Sciences, Research Group 'Ubiquitin Signaling Specificity', Göttingen, Germany.
Nature communications
|September 2, 2025
まとめ
ヒトのリガゼHUWE1は タンパク質だけでなく 薬剤の小さな分子も 変化させることができます この発見により 薬の開発にユビキチン系を活用する 新しい方法が明らかになりました
科学分野:
- 生物化学
- 分子生物学
- 薬物の発見
背景:
- ユビキチン系は,真核生物のタンパク質機能の調節に不可欠である.
- ユビキチンリガゼは基板特異性を決定し,ユビキチンシグナルアセンブリを制御する.
- いくつかのウビキチンリガゼは非タンパク質のバイオ分子を修正し,既知の機能を拡張します.
研究 の 目的:
- ヒトのリガゼHUWE1が 薬のような小分子を標的とするかどうかを調査する.
- 異質の小分子を改造するためにユビキチン系を使用する可能性を調査する.
主な方法:
- HUWE1と小分子化合物を用いた in vitro ユビキチネーション測定法
- 細胞内の化合物のユビキチン化を確認するための細胞検出方法の開発.
- 化合物のユビキチン化に関与する触媒カスケードの分析
主要な成果:
- ヒトのリガゼHUWE1は,薬のような小分子を標的にすることが判明しました.
- 以前 HUWE1 阻害体として特定された化合物は,リガースの基板です.
- 化合物のウビキチネーションは,カノニカル触媒カスケードを経て,ウビキチンを分子の主なアミノ基に結合させます.
- HUWE1は,タンパク質基質と競合して,化合物のユビキチン化をインビトロで選択的に触媒化する.
- 細胞実験では,HUWE1が化合物のユビキチネーションを促進するが,ただ単に誘導するものではないことが確認された.
結論:
- 既存の化合物は,特異性の高い特定のHUWE1基板または阻害剤に変換できます.
- この発見は,細胞内の小さな分子から新しい化学的様式を作成するために,ユビキチンシステムを活用する新しい可能性を開きます.
関連する概念動画
Regulated Protein Degradation
7.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.6K
The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
The Proteasome Structure
958
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
958
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K

